Soul Biotechnology Corporation filed its 10-K on Mar 13, 2023 for the period ending Dec 31, 2022. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
1st Jan change | Capi. | |
---|---|---|
+37.93% | 705B | |
+32.82% | 583B | |
-3.66% | 364B | |
+20.21% | 332B | |
+4.95% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.79% | 169B |